Title {1}	Efficacy of a two-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial
Trial registration {2a and 2b}	ClinicalTrials.gov: Identifier:(NCT06065267 direct link https://clinicaltrials.gov/study/NCT06065267). Efficacy of a two-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial
Protocol version {3}	Protocol version 3.0, December 24,2023
Funding {4}	Scientific research fund of Damascus Hospital, No. GD-23091
Author details {5a}	All authors are affiliated with Damascus Hospital
Name and contact information for the trial sponsor {5b}	Grantee and trial sponsor: Damascus Hospital Contact name: Dr.Ahmad Abbas, general manager of Damascus hospital Address: No. Syria, Damascus, Almujtahed Street, Damascus Hospital Telephone: + 963992490396 E-mail: ahmadJabbas@outlook.com
Role of sponsor {5c}	The grantee and sponsor (Damascus Hospital) will not be a part of the trial procedures (including trial design, gathering data, data management, data analysis and interpretation, report writing, and publication decision). The sponsor has no authority over any of the mentioned activities